CLEO Diagnostics Ltd (AU:COV) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Cleo Diagnostics Ltd has announced their Annual General Meeting (AGM) for shareholders, scheduled for 10:30 am on November 27, 2024, at FB Rice’s Melbourne offices. Shareholders will review the company’s Annual Report for the fiscal year ending June 30, 2024, and vote on key resolutions, including the adoption of the Remuneration Report and the re-election of Director Adrien Wing.
For further insights into AU:COV stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue